accuraci
diagnos
influenza
viru
infect
basi
symptom
alon
limit
symptom
ill
caus
respiratori
pathogen
overlap
earli
accur
identif
influenza
reduc
inappropri
use
antibiot
inform
treatment
decis
regard
use
influenza
antivir
sever
influenza
diagnost
assay
commerci
avail
includ
rapid
influenza
diagnost
test
ridt
immunoassay
identifi
viral
antigen
respiratori
specimen
recent
molecular
base
assay
detect
viral
nucleic
acid
respiratori
prior
influenza
pandem
us
public
health
infrastructur
capac
quickli
accur
detect
influenza
virus
includ
novel
influenza
virus
establish
capac
depend
upon
build
maintain
molecular
diagnost
capac
influenza
virus
among
public
health
laboratori
unit
greatli
strengthen
molecular
diagnost
capac
influenza
among
public
health
laboratori
unit
state
howev
less
known
laboratori
capac
routin
diagnos
influenza
respiratori
virus
clinic
laboratori
hospit
object
describ
influenza
respiratori
viru
diagnost
practic
routin
laboratori
test
capac
sampl
laboratori
serv
hospit
unit
state
hospit
associ
laboratori
hospit
extern
contract
laboratori
particip
influenza
hospit
surveil
network
includ
network
cover
counti
state
ca
co
ct
ga
md
mn
nm
ny
tn
ia
mi
oh
ri
ut
catchment
popul
million
peopl
surveil
base
identif
posit
laboratori
result
influenza
howev
whether
hospit
patient
test
influenza
depend
upon
clinic
practic
team
care
individu
patient
particip
hospit
laboratori
ask
voluntarili
send
influenza
specimen
state
public
health
laboratori
subtyp
network
site
also
ask
hospit
laboratori
send
specimen
public
health
laboratori
improv
case
number
influenza
season
administ
standard
questionnair
key
personnel
hospit
telephon
interview
first
part
questionnair
administ
infect
control
practition
assess
characterist
hospit
polici
place
test
patient
acut
respiratori
ill
emerg
depart
ed
avail
influenza
poc
test
design
use
near
site
patient
locat
allow
time
diagnosi
second
part
questionnair
administ
head
laboratori
depart
designe
collect
inform
diagnost
capac
influenza
respiratori
virus
laboratori
question
includ
type
laboratori
test
avail
specimen
type
accept
test
turnaround
time
molecular
diagnost
test
test
algorithm
confirm
initi
result
compar
laboratori
capac
influenza
test
result
collect
similar
survey
conduct
subset
current
network
site
ca
co
ct
ga
md
mn
nm
ny
tn
era
influenza
season
sc
chave
unpublish
use
test
analys
perform
sa
sa
institut
cari
nc
usa
particip
hospit
catchment
area
respond
survey
locat
urban
area
ie
popul
densiti
peopl
per
squar
mile
wherea
remaind
locat
suburban
rural
area
approxim
half
n
hospit
fewer
bed
hospit
repres
varieti
practic
includ
gener
hospit
children
hospit
veteran
affair
hospit
specialti
hospit
hospit
affili
academ
institut
equip
gener
ed
major
hospit
polici
place
systemat
test
patient
acut
respiratori
infect
ari
present
ed
influenza
season
influenza
hospit
polici
place
test
patient
ari
locat
urbansuburban
area
test
polici
associ
hospit
size
academ
affili
hospit
appli
test
polici
adult
children
sixti
hospit
perform
ridt
influenza
season
directli
ed
clinic
ie
test
ed
outpati
clinic
inpati
ward
hospit
urban
affili
less
bed
differ
avail
poc
test
hospit
polici
test
patient
influenza
influenza
season
versu
p
two
hundr
hospit
laboratori
independ
laboratori
eg
refer
commerci
physician
offic
satellit
clinic
respond
survey
laboratori
least
one
influenza
diagnost
assay
avail
ridt
frequent
use
follow
molecular
assay
viral
cultur
direct
indirect
fluoresc
antibodi
assay
dfaifa
serolog
ridt
diagnost
test
avail
influenza
laboratori
compar
result
survey
conduct
proport
laboratori
report
use
molecular
assay
increas
significantli
season
versu
respect
p
use
viral
cultur
dfaifa
slightli
decreas
figur
among
laboratori
revers
transcript
polymeras
chain
reaction
capac
develop
influenza
assay
hous
abl
subtyp
influenza
virus
laboratori
capabl
provid
test
result
within
day
among
ran
test
immedi
need
six
laboratori
perform
test
variou
frequenc
within
week
among
local
hospit
laboratori
avail
data
use
molecular
test
techniqu
inpati
influenza
test
figur
among
laboratori
perform
ridt
first
choic
influenza
diagnost
report
posit
neg
result
back
physician
final
without
proceed
confirmatori
test
laboratori
like
send
posit
ridt
result
confirm
neg
ridt
result
versu
reflect
particip
surveil
influenza
viru
subtyp
confirmatori
test
sent
perform
correspond
state
public
health
refer
laboratori
overal
laboratori
abl
perform
kind
test
respiratori
virus
tabl
offer
molecular
multivir
panel
often
includ
influenza
viru
respiratori
syncyti
viru
rsv
parainfluenza
virus
human
metapneumoviru
hmpv
human
rhinovirus
adenovirus
among
laboratori
perform
test
respiratori
virus
influenza
abl
test
rsv
adenoviru
parainfluenza
virus
hmpv
rhinoviru
coronaviru
rapid
rsv
diagnost
test
frequent
use
rsv
test
molecular
assay
respiratori
virus
common
test
avail
molecular
assay
includ
luminex
filmarray
nucleic
acid
test
nat
assay
demonstr
predomin
use
rapid
diagnost
test
influenza
rsv
among
hospit
laboratori
state
use
molecular
diagnost
assay
detect
influenza
viru
infect
hospit
associ
commerci
laboratori
increas
modestli
sinc
avail
influenza
molecular
diagnost
clinic
care
hospit
still
limit
hospit
laboratori
report
avail
molecular
diagnost
assay
laboratori
diagnost
respiratori
virus
influenza
rsv
uncommonli
avail
also
minor
hospit
includ
survey
polici
place
systemat
test
patient
acut
respiratori
infect
ari
seen
ed
influenza
diagnost
influenza
season
number
type
commerci
avail
laboratori
diagnost
respiratori
pathogen
evolv
updat
survey
warrant
show
hospit
includ
us
surveil
network
involv
state
ridt
clinician
primari
option
influenza
diagnost
test
ridt
easi
use
rapid
turnaround
time
result
howev
ridt
shown
suboptim
sensit
compar
viral
sever
studi
suggest
healthcar
provid
like
prescrib
antivir
drug
posit
therefor
result
may
affect
clinician
decis
provid
appropri
treatment
infect
control
among
patient
influenza
given
suboptim
sensit
ridt
patient
manag
depend
upon
posit
ridt
result
patient
manag
depend
upon
diagnosi
rule
influenza
addit
confirmatori
test
sensit
assay
warrant
initi
antivir
treatment
implement
infect
control
start
empir
delay
await
survey
laboratori
protocol
confirmatori
test
sensit
assay
follow
neg
rapid
test
result
may
reflect
limit
use
receiv
test
result
late
clinic
care
also
survey
laboratori
confirm
ridt
test
result
reflect
shipment
specimen
state
public
health
laboratori
part
surveil
addit
clinician
practic
new
molecular
assay
may
improv
accuraci
influenza
diagnosi
timeli
cost
new
assay
could
affect
futur
use
survey
limit
survey
complet
may
repres
laboratori
recent
season
especi
light
expand
commerci
avail
molecular
assay
may
repres
hospit
laboratori
unit
state
hospit
catchment
area
regular
correspond
state
health
depart
may
better
access
laboratori
diagnost
elsewher
physician
set
may
awar
import
earli
diagnosi
influenza
viral
pathogen
nonetheless
provid
overview
local
laboratori
capac
nation
reflect
hospit
vari
characterist
support
laboratori
final
hospit
laboratori
respond
survey
provid
case
may
differ
particip
laboratori
conclus
survey
suggest
hospit
unit
state
heavili
depend
ridt
diagnos
influenza
relianc
upon
insensit
assay
may
compromis
patient
treatment
infect
control
increas
use
molecular
assay
respiratori
virus
may
improv
patient
care
surveil
respiratori
virus
influenza
hospit
surveil
network
collabor
state
health
depart
academ
institut
local
partner
fund
center
diseas
control
prevent
cdc
public
support
part
cooper
agreement
number
cdc
content
sole
respons
author
necessarili
repres
offici
view
center
diseas
control
prevent
us
depart
health
human
servic
